FORTFLOX

This brand name is authorized in Nigeria.

Active ingredients

The drug FORTFLOX contains one active pharmaceutical ingredient (API):

1	Sparfloxacin UNII Q90AGA787L - SPARFLOXACIN
	Sparfloxacin, an aminodifluoroquinolone, has in vitro activity against a wide range of gramnegative and gram-positive microorganisms. Sparfloxacin exerts its antibacterial activity by inhibiting DNA gyrase, a bacterial topoisomerase. In vitro tests show that the combination of sparfloxacin and rifampin is antagonistic against Staphylococcus aureus.

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-1642	Tablet	Fortflox 200 Tablets TAB 200 mg 1 x 10's (in blister)	Tablet	29/03/2021
C4-1680	Tablet	Fortflox 400 Tablets TAB 400 mg 1 x 10's (in blister)	Tablet	07/05/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA09	Sparfloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-1642, C4-1680